Warning over morning-after-pill for women with epilepsy
Women with epilepsy are being advised to consult their doctor, pharmacist or specialist nurse if they are using the morning-after-pill containing levonorgestrel.
Epilepsy drug Trobalt (retigabine) to be discontinued
The epilepsy drug Trobalt, also known as retigabine, is to be discontinued and will no longer be available after June 2017.
Study finds 83 per cent of people with epilepsy also have headaches
A study has found that headaches cause a ‘burden’ to the quality of life of many people with epilepsy.
Suicide rate among people with epilepsy is 22 per cent greater than the general population
The suicide rate among people with epilepsy has been found to be 22 per cent higher than in the general population in a study by the Centers for Disease Control and Prevention (CDC) in the United States.
Study finds link between smoking and epilepsy
There appears to be a correlation between epilepsy and smoking, a study of people living in French-speaking Switzerland has found.
Caution advised over new links between pregabalin and birth defects
Epilepsy Society's medical director Professor Ley Sander has advised women who are taking pregabalin not to panic over new research which suggests the epilepsy drug could pose risks for an unborn child if taken during pregnancy.